Pages that link to "Q79776202"
Jump to navigation
Jump to search
The following pages link to Expression of phosphorylated ERK1/2 and homeodomain protein CDX2 in cholangiocarcinoma (Q79776202):
Displaying 11 items.
- Combination of celecoxib and PD184161 exerts synergistic inhibitory effects on gallbladder cancer cell proliferation (Q33684263) (← links)
- Roles of the MEK1/2 and AKT pathways in CXCL12/CXCR4 induced cholangiocarcinoma cell invasion (Q34099141) (← links)
- Expression of CDX2 and Hepatocyte Antigen in Benign and Malignant Lesions of Gallbladder and Its Correlation with Histopathologic Type and Clinical Outcome (Q35173168) (← links)
- Prognostic significance of Cdx2 immunohistochemical expression in gastric cancer: a meta-analysis of published literatures (Q36498827) (← links)
- Activation of MAP kinase signaling through ERK5 but not ERK1 expression is associated with lymph node metastases in oral squamous cell carcinoma (OSCC). (Q36640209) (← links)
- Expression of phospho-ERK1/2 and PI3-K in benign and malignant gallbladder lesions and its clinical and pathological correlations (Q37215137) (← links)
- DUSP1 inhibits cell proliferation, metastasis and invasion and angiogenesis in gallbladder cancer (Q37707060) (← links)
- Secreted cyclophilin A mediates G1/S phase transition of cholangiocarcinoma cells via CD147/ERK1/2 pathway (Q38949695) (← links)
- Dual blockade of the Hedgehog and ERK1/2 pathways coordinately decreases proliferation and survival of cholangiocarcinoma cells (Q40172180) (← links)
- Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype (Q50871791) (← links)
- The expression and clinicopathological role of CDX2 in intrahepatic cholangiocarcinoma. (Q55312215) (← links)